pI: 6.4383 |
Length (AA): 619 |
MW (Da): 66187 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 504 | 3mfi (A) | 23 | 506 | 27.00 | 0 | 1 | 0.924316 | 0.62 |
1 | 507 | 3gqc (A) | 416 | 827 | 17.00 | 0 | 1 | 0.499763 | 1.87 |
2 | 428 | 4j9o (A) | 7 | 351 | 35.00 | 0 | 1 | 0.699922 | 1.12 |
188 | 291 | 3p5m (A) | 44 | 148 | 36.00 | 0.59 | 0.08 | 0.0901129 | 2.28 |
233 | 431 | 4f4y (A) | 127 | 328 | 20.00 | 0 | 0.77 | 0.398186 | 1.11 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128521)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G44740 | Y-family DNA polymerase H |
Brugia malayi | Bm1_21045 | ImpB/MucB/SamB family protein |
Candida albicans | CaO19.866 | similar to S. cerevisiae DNA polymerase pol-eta, involved in the bypass of distorted DNA lesions |
Candida albicans | CaO19.8485 | similar to S. cerevisiae DNA polymerase pol-eta, involved in the bypass of distorted DNA lesions |
Caenorhabditis elegans | CELE_F53A3.2 | Protein POLH-1 |
Cryptosporidium parvum | cgd4_3920 | DinB/family X-type DNA polymerase |
Drosophila melanogaster | Dmel_CG7143 | CG7143 gene product from transcript CG7143-RA |
Echinococcus granulosus | EgrG_001106600 | dna polymerase eta |
Echinococcus multilocularis | EmuJ_001106600 | dna polymerase eta |
Homo sapiens | ENSG00000170734 | polymerase (DNA directed), eta |
Leishmania braziliensis | LbrM.21.0680 | DNA polymerase eta, putative |
Leishmania braziliensis | LbrM.21.0690 | DNA polymerase eta, putative |
Leishmania infantum | LinJ.21.0680 | DNA polymerase eta, putative |
Leishmania infantum | LinJ.21.0690 | DNA polymerase eta, putative |
Leishmania major | LmjF.21.0630 | DNA polymerase eta, putative |
Leishmania major | LmjF.21.0620 | DNA polymerase eta, putative |
Leishmania mexicana | LmxM.21.0630 | |
Leishmania mexicana | LmxM.21.0620 | DNA polymerase eta, putative |
Loa Loa (eye worm) | LOAG_06542 | hypothetical protein |
Mus musculus | ENSMUSG00000023953 | polymerase (DNA directed), eta (RAD 30 related) |
Neospora caninum | NCLIV_042210 | Pc21g17280 protein, related |
Oryza sativa | 4325305 | Os01g0757800 |
Saccharomyces cerevisiae | YDR419W | Rad30p |
Schistosoma japonicum | Sjp_0072790 | ko:K03509 DNA polymerase eta subunit, putative |
Schistosoma japonicum | Sjp_0116210 | ko:K03509 DNA polymerase eta subunit, putative |
Schistosoma mansoni | Smp_136180 | DNA polymerase eta |
Schmidtea mediterranea | mk4.000539.14 | |
Trypanosoma brucei gambiense | Tbg972.10.2030 | DNA polymerase eta, putative |
Trypanosoma brucei | Tb927.10.1710 | DNA polymerase eta, putative |
Trypanosoma congolense | TcIL3000_10_1450 | DNA polymerase eta, putative |
Trypanosoma cruzi | TcCLB.511911.120 | DNA polymerase eta, putative |
Trypanosoma cruzi | TcCLB.508637.79 | DNA polymerase eta, putative |
Toxoplasma gondii | TGME49_234580 | ImpB/MucB/SamB family protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.1710 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.1710 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.1710 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.1710 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_234580 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed), eta | Compounds | References |